Bevacizumab treatment in hereditary hemorrhagic teleangiectasia.
Sebastian
S
Föllner
Michael
M
Ibe
Jens
J
Schreiber
D016907:Adverse Drug Reaction Reporting Systems / Q000706:statistics & numerical data*; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D016208:Databases, Factual; D005260:Female; D006801:Humans; D008297:Male; D060735:Pharmacovigilance
D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized